DFG guideline for quality-enhancing aspects

The "Permanent Senate Commission on Fundamental Questions in Clinical Research" of the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) has published a guideline that helps to systematically describe quality-enhancing aspects in funding proposals and thus to better take them into account in review and evaluation.

The quality of research projects often only becomes visible after the funding has been completed and is ultimately reflected in the comprehensibility and reproducibility of the results, but also in the integrability of the knowledge gained in the project. There are a number of aspects that should be taken into account when planning a project in order to enable high-quality findings.

On the basis of an exchange with representatives of life science expert boards – including Prof. Dr. Michael Hummel, head of the German Biobank Node (GBN), and Prof. Dr. Hans-Ulrich Prokosch, member of the GBN steering committee – the working group "Quality in Clinical Research" of the Permanent Senate Commission on Fundamental Questions in Clinical Research has identified the essential quality-enhancing measures for medical and biomedical research and compiled them in a short guideline. The choice of research model or theoretical approach, the quality of the biospecimens and data sets used, and the use of suitable research infrastructures – including certified biobanks – were identified as particularly central points. In addition, appropriate statistical planning and approaches to avoid bias contribute significantly to the quality of results in these disciplines.

More information and links:

Questions?

germanbiobanknode@charite.de

Tel. +49. 30. 450 536 347


Fax +49. 30. 450 753 69 38

BMBF
top
Biobank Directory European Biobank Directory GBN products Download templates, manuals and other materials